Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves'

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05774535` - Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery
Completed	`NCT02973802` - ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid Therapy	Phase 1
Completed	`NCT02491567` - DNA Methylation and Autoimmune Thyroid Diseases
Terminated	`NCT01320813` - Trial Comparing Complication Rates Associated With Robot-assisted Thyroidectomy to External Thyroidectomy	N/A
Completed	`NCT00432146` - Effect of Lugol's Solution in the Patients With Graves' Disease	N/A
Recruiting	`NCT06081439` - Validating Immunological Markers Associated With Mental Fatigue in Graves' Disease
Not yet recruiting	`NCT06327828` - Methimazole in Graves' Disease - Comparing the Computer-aided Treatment DigiThy Versus Usual Care	N/A
Recruiting	`NCT05635266` - Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Completed	`NCT01727973` - Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy	Phase 1/Phase 2
Active, not recruiting	`NCT04135573` - The Relationship Between NK Cell and Graves' Disease
Recruiting	`NCT06134219` - Course for Brain Fatigue After Graves' Disease Controlled Study	N/A
Completed	`NCT04239521` - The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
Recruiting	`NCT05678374` - Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease
Completed	`NCT03009357` - Clinical Application of Pulse Rate-monitoring Activity Trackers in Thyrotoxicosis
Recruiting	`NCT05510609` - Three-dimensional Ultrasonography Thyroid Volume Measurement.	N/A
Not yet recruiting	`NCT06426758` - Graves' Disease Induced by Epstein-Barr Virus Lytic Reactivation
Recruiting	`NCT05907668` - A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves' Disease	Phase 2
Recruiting	`NCT06275373` - The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction
Recruiting	`NCT03303053` - Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt Hyperthyroidism	Phase 3
Recruiting	`NCT05461820` - Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease	Phase 4

NCT number	NCT03498417
Study type	Observational
Source	University of Pisa
Contact
Status	Completed
Phase
Start date	June 20, 2018
Completion date	July 20, 2018

Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy — IGF1RAbsGO

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms